title: Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits.
abstract: The liver is the most common site of hematogenous metastases from colorectal carcinoma. Kupffer cells (KC), which line the hepatic sinusoids, may form the first line of defense against circulating tumor cells. The purpose of this study was to determine the effect of hepatic metastases and intra-abdominal tumor growth on KC binding of human colorectal carcinoma (HCRC) cells. MIP-101, a poorly metastatic cell line, and CX-1, a highly metastatic cell line, were injected intrasplenically into nude mice and KC were isolated by collagenase perfusion at varying intervals after injection. Conditioned media were collected from MIP-101, CCL 188 and CX-1 to determine their in vitro effect on KC function. KC from MIP-101 injected mice (14% liver metastases, 100% splenic tumors) bound a significantly greater number of MIP-101 and clone A cells than CX-1 cells in vitro. KC isolated from mice 5 weeks after CX-1 injection (100% liver metastases) also showed increased binding of MIP-101 and clone A cells compared to CX-1 cells. Similar results were obtained when tumor cell binding to normal human liver KC was compared to binding to KC from human livers from patients with hepatic metastasis from colorectal cancer. In contrast KC obtained from mice 3 weeks after CX-1 injection (44% liver metastases) showed significantly decreased binding of MIP-101 and clone A cells. The conditioned medium from CX-1 cells significantly decreased the in vitro binding of both MIP-101 and CX-1 by KC. These results indicate that the ability of KC to bind HCRC cells (which precedes phagocytosis and tumor cell killing) is a dynamic function and affected by concomitant tumor growth. HCRC cells may alter KC function via the production of specific tumor-derived soluble factors. In order to devise new and more effective therapeutic options in the treatment of liver metastases the nature of this tumor cell-KC interaction must be better understood.
authors.affiliation: Department of Surgery, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02115.
authors.forename: S
authors.initials: S
authors.lastname: Meterissian
authors.forename: G D
authors.initials: GD
authors.lastname: Steele
authors.forename: P
authors.initials: P
authors.lastname: Thomas
mesh_terms: D000818:Animals; D002448:Cell Adhesion; D015179:Colorectal Neoplasms / Q000473:pathology; D017077:Culture Media, Conditioned; D006801:Humans; D007728:Kupffer Cells / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D008114:Liver Neoplasms, Experimental / Q000503:physiopathology* / Q000556:secondary*; D008264:Macrophages / Q000502:physiology; D051379:Mice; D008819:Mice, Nude; D013160:Splenic Neoplasms / Q000503:physiopathology / Q000556:secondary*; D014407:Tumor Cells, Cultured
chemical_list: D017077:Culture Media, Conditioned